Clinical Trials Logo
  1. Home
  2. Staphylococcus Aureus Bacteremia
  3. NCT06249451

Staphylococcus Aureus Bacteraemia (SAB)-Support-Study — SABOT  

Staphylococcus Aureus Bacteremia Clinical Trial

Official title:
SAB-Support-Study: Can Checklist-based Phone Calls Improve the Quality of Staphylococcus Aureus Bacteraemia (SAB) Management

Clinical Trial Summary

The main objective of this study is to investigate whether checklist-based close telephone consultation and process surveillance for S. aureus bacteraemia (SAB) can improve adherence to our in-house SAB-guidelines (prospective quality- improvement group). In addition, the effects of telephone consultation on the clinical outcome of patients will be examined.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT06249451
Study type Interventional
Source University Medicine Greifswald
Contact Lena Ulm
Phone 00493834865569
Email lena.ulm@med.uni-greifswald.de
Status Recruiting
Phase N/A
Start date January 22, 2024
Completion date April 23, 2025
View Details
See also
  Status Clinical Trial Phase
Recruiting NCT05862025 - Evaluation of the Usefulness of Echocardiography in Patients With Staphylococcus Aureus Bacteremia (ET-AUREUS Study). N/A
Not yet recruiting NCT05361135 - 18-fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in S. Aureus Bacteraemia N/A
Recruiting NCT00622882 - Early Infectious Disease Consultations in Staphylococcus Aureus Bacteremia N/A
Recruiting NCT06168474 - Evaluating Simplified Layered Consent for Clinical Trials N/A
Completed NCT03163446 - Safety, Efficacy and Pharmacokinetics of CF-301 vs. Placebo in Addition to Antibacterial Therapy for Treatment of S. Aureus Bacteremia Phase 2
Not yet recruiting NCT06336824 - Early Intravenous to Oral Antibiotic Switch in Uncomplicated Staphylococcus Aureus Bacteraemia Phase 3
Completed NCT02357966 - A Study of the Safety and Efficacy of 514G3 in Subjects Hospitalized With Bacteremia Due to Staphylococcus Aureus Phase 1/Phase 2
Recruiting NCT04886284 - Combination Cefazolin With Ertapenem for Methicillin-susceptible Staphylococcus Aureus Bacteremia Phase 2
Terminated NCT03089697 - Phase IIa Clinical Study of N-Rephasin® SAL200 Phase 2
Recruiting NCT03514446 - Seven Versus Fourteen Days of Treatment in Uncomplicated Staphylococcus Aureus Bacteremia Phase 4
Withdrawn NCT03761953 - Oritavancin for Staphylococcus Aureus Infections in Opioid Users Phase 4
Recruiting NCT02098850 - Staphylococcus Aureus Bacteraemia in Adults N/A
Completed NCT01701219 - Safety and Efficacy Study of Ceftaroline in Subjects With Staphylococcus Aureus Bacteremia or With Persistent Methicillin-Resistant Staphylococcus Aureus Bacteremia Phase 4
Recruiting NCT05137119 - Staphylococcus Aureus Network Adaptive Platform Trial Phase 4
Completed NCT03908086 - Bloodstream Infections in Patients With Rheumatoid Arthritis
Terminated NCT04160468 - Direct Lysis of Staph Aureus Resistant Pathogen Trial of Exebacase Phase 3
Completed NCT03138733 - Ceftobiprole in the Treatment of Patients With Staphylococcus Aureus Bacteremia Phase 3
Completed NCT02476487 - The Benefit of FDG PET CT in the Treatment Algorithm of Staphylococcus Aureus Bacteremia N/A
Recruiting NCT05184764 - Study Evaluating Safety, Tolerability, and Efficacy of Intravenous AP-SA02 in Subjects With S. Aureus Bacteremia Phase 1/Phase 2
Completed NCT01971762 - Staphylococcus Aureus Bacteremia: Impact of an Intervention Program in Improving the Clinical Management and Review of the Clinical and Molecular Epidemiology N/A